Effect of colchicine on chronic ciclosporin nephrotoxicity in Sprague-Dawley rats. 1998

M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
Urology and Nephrology Center, University of Mansûra, Egypt.

Thirty male Sprague-Dawley rats were given ciclosporin (Cs) orally, 15 mg/kg daily for 80 days. Fifteen served as positive controls, while the other 15 were given daily colchicine at a dose of 30 microg/kg in addition to Cs. Additional 15 rats were given olive oil only and served as negative controls. The animals were subjected every other week to laboratory assessment of serum creatinine, sodium, potassium, and Cs whole-blood trough levels; also urine samples were examined for creatinine, sodium, potassium, and protein concentrations. At the end point, the animals were sacrificed, and kidney tissue was examined for histopathological changes. Comparing negative control versus Cs-treated and Cs-plus-colchicine-treated rats, there were no significant differences in serum creatinine, creatinine clearance, and serum and urine values of sodium and potassium as well as urinary protein/creatinine ratios. Yet histopathological examination of kidney tissues showed focal tubular atrophy and interstitial fibrosis in inner medulla and inner stripe of the outer medulla in all Cs-treated animals and in only 1 of the colchicine-treated group, but in none of the negative controls. Histological changes in other kidney zones in different animal groups were minor and not different. From this study, we may conclude that colchicine is of protective value against chronic Cs nephrotoxicity in Sprague-Dawley rats.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007672 Kidney Cortex The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. Cortex, Kidney
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007679 Kidney Medulla The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. Kidney Papilla,Kidney Medullas,Kidney Papillas,Medulla, Kidney,Medullas, Kidney,Papilla, Kidney,Papillas, Kidney
D008297 Male Males
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
November 2005, The Journal of pharmacy and pharmacology,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
November 2006, Archives of medical research,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
April 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
August 2003, Urology,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
January 1995, Toxicology letters,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
January 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
September 2006, Journal of ethnopharmacology,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
December 2012, Journal of ethnopharmacology,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
July 2022, Pakistan journal of pharmaceutical sciences,
M Sobh, and A Sabry, and F Moustafa, and M A Foda, and S Sally, and M Ghoneim
May 2015, Journal of medicinal food,
Copied contents to your clipboard!